Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Trading Statement

15 Oct 2009 10:00

RNS Number : 8230A
PureCircle Limited
15 October 2009
 



PureCircle Limited ('PureCircle' or 'the Company') 

PureCircle Announces Successful Completion of Next Stage of Global Expansion and DiversificationPureCircle (LSE: PURE), the world's leading producer of Natural High Intensity Sweeteners, including Reb A, is pleased to report that it has signed a co-operation and mutual investment agreement with the Government Agency of the United States for International Development (USAID) and the Government of Paraguay to promote the cultivation of the stevia leaf, from which Reb A is derived. PureCircle is the first company in the region to successfully complete the development agreements necessary to accelerate stevia development and markets to the next level. In response to accelerating demand from Western economies, an important part of PureCircle's strategy is to maintain a significant and diversified lead in the world's stevia supply chain of several years in production of stevia, not only in China but on other continents. Currently the Company sources the leaf mainly from China and for three years it has been expanding its reach within Paraguay, investing heavily in local infrastructure.

This has resulted in the agreement with USAID and the Paraguayan Government as part of the Paraguay Vende economic growth programme. PureCircle's stevia program is acknowledged by USAID and Paraguay's Government Agency as offering significant commercial and social development opportunities for regional development in Paraguay and South America.  PureCircle is committed to investing in community projects in the areas in which it operates. Stevia is grown by small farmers and the support of the Company for this community has been partly responsible for the local economic well-being where the leaf is grown. Additionally, because it contains zero calories, the use of stevia in its various forms, including Reb A, is a vital factor in the worldwide battle to combat obesity and diabetes Dorn Wenninger, PureCircle's Corporate Vice President of Supply Chain, said: "The decision by USAID and the government of Paraguay to select and invest with PureCircle, illustrates the enormous commercial opportunities and socio-economic benefits that stevia cultivation is bringing to South America. While our competitors are just beginning  to explore co-operations in Paraguay and South America, we are yielding the benefit of several years of pre-existing investment in a 100 per cent subsidiary in Paraguay. This coupled with the proprietary high yielding stevia strains developed internally and registered with Plant Breeders Rights inevitably gives us strong demonstrable commercial advantages. This is a significant day for stevia growth and PureCircle in the region".

Enquiries

PureCircle Limited (www.purecircle.com),

Magomet Malsagov, Managing Director

 +60 1 2388 8049 

William Mitchell, Finance Director 

+44 7974 005 163

Westport Communications

+44 20 7065 2690 

Alan Frame

alan@westportcomms.com

Jeanette Bishop

jeanette@westportcomms.com

RFC Corporate Finance Ltd

+61 8 9480 2500

Stephen Allen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVELBFKBBEFBB
Date   Source Headline
6th Jul 20157:00 amRNSPRECLOSE PERIOD UPDATE FY 2015
24th Apr 20157:00 amRNSAcquisition of remaining equity interest in PCJX
13th Apr 20157:23 amRNSDealings in Shares
10th Apr 20157:00 amRNSExercise of Options and Movement Treasury Shares
16th Mar 20157:00 amRNSInterim Results
9th Mar 20157:00 amRNSAnnouncement of Interim Results
28th Jan 20157:00 amRNSSustainability Report
27th Jan 20157:00 amRNSNotification of a Major Interest
14th Jan 20157:00 amRNSGrant of Options and Movement of Treasury Shares
5th Jan 20157:00 amRNSTrading Update
4th Dec 20147:00 amRNSResult of AGM
21st Nov 20147:00 amRNSHolding(s) in Company
12th Nov 20147:00 amRNSCompletion of Placement
11th Nov 20147:06 amRNSHolding(s) in Company
5th Nov 20147:00 amRNSNotice of AGM and Annual Report
4th Nov 20147:00 amRNSIncrease in Private Placement
22nd Oct 20147:00 amRNSDealings in Shares
21st Oct 20147:00 amRNSPrivate Placement to Support Accelerated Growth
14th Oct 20147:00 amRNSPublication of Annual Report
26th Sep 20147:00 amRNSDirector Share Transfer
19th Sep 20147:00 amRNSGrant of Options and Movement of Treasury Shares
10th Sep 20147:00 amRNSFinal Results
3rd Sep 20147:00 amRNSAnnouncement of Prelims & Investor Conference Call
4th Jul 20147:00 amRNSOptions Granted To and Exercised by Directors
2nd Jul 20147:04 amRNSPRECLOSE PERIOD UPDATE 2H FY 2014
17th Jun 20147:00 amRNSManagement Changes
10th Jun 20147:50 amRNSHolding(s) in Company
8th May 20147:00 amRNSDealings in Shares
2nd May 20147:00 amRNSExercise of Options
25th Apr 20147:00 amRNSDealings in Shares
8th Apr 20147:00 amRNSDirector's Shareholding
28th Mar 20147:00 amRNSExercise of Options
25th Mar 20147:50 amRNSHolding(s) in Company
19th Mar 20147:00 amRNSInterim Results
18th Mar 20147:00 amRNSBoard Change
10th Mar 20147:00 amRNSAnnouncement of Interim Results and Investor Call
10th Jan 20147:00 amRNSOptions Granted To and Exercised by Directors
6th Jan 20147:00 amRNSTrading Update
30th Dec 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside M
3rd Dec 20137:00 amRNSResult of AGM
28th Nov 20137:45 amRNSHolding(s) in Company
14th Nov 20137:00 amRNSDealings in Shares
6th Nov 20137:00 amRNSNotice of AGM and Annual Report
8th Oct 20137:00 amRNSLTIP Options Awarded - Options Issued to Directors
16th Sep 20137:00 amRNSFinal Results
3rd Sep 20137:00 amRNSAppointment of Broker and New Financing Facility
2nd Sep 20137:00 amRNSAnnouncement of Prelims & Investor Conference Call
19th Jul 20138:13 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSChange of Brokers
9th Jul 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside D

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.